unknown
Stage
About
Atanis Biotech develops FAST-PASE®, a precision allergy diagnostic test that uses a small blood sample to measure cellular allergic responses safely and accurately without exposing patients to allergens.
Explore Atanis Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.